Hirokazu Shiraishi

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

The Muscle Protein Dok-7 Is Essential for Neuromuscular Synaptogenesis

Kumiko Okada, Akane Inoue, Momoko Okada et al. · Science · 2006 · 425 citations

Muscle-specific Receptor Kinase, Developmental Biology, Molecular Neuroscience +15

JCS/JACR 2021 Guideline on Rehabilitation in Patients With Cardiovascular Disease

Shigeru Makita, Takanori Yasu, Yoshihiro J. Akashi et al. · Circulation Journal · 2022 · 259 citations · Full text

Acetylcholine receptors loss and postsynaptic damage in MuSK antibody–positive myasthenia gravis

Hirokazu Shiraishi, Masakatsu Motomura, Toshiro Yoshimura et al. · Annals of Neurology · 2005 · 171 citations

c-Raf/MEK/ERK Pathway Controls Protein Kinase C-mediated p70S6K Activation in Adult Cardiac Muscle Cells

Yoshihiro Iijima, Martin Laser, Hirokazu Shiraishi et al. · Journal of Biological Chemistry · 2002 · 157 citations · Full text

Cardiac Muscle, Cardiomyopathy, Ribosomal Biogenesis +15